Norges Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Norges Bank’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-145,582	Closed	-$14.8M	–	2054
2023 Q2	$14.8M	Sell	145,582 -19,900	-12%	-$1.88M	﹤0.01%	1389
2023 Q1	$15M	Sell	165,482 -39,837	-19%	-$2.34M	﹤0.01%	1409
2022 Q4	$7.8M	Buy	205,319 +6,589	+3%	+$227K	﹤0.01%	1639
2022 Q3	$4.99M	Hold	198,730	–	–	﹤0.01%	1766
2022 Q2	$6.04M	Buy	198,730 +10,848	+6%	+$324K	﹤0.01%	1725
2022 Q1	$6.16M	Sell	187,882 -30,843	-14%	-$915K	﹤0.01%	1829
2021 Q4	$5.77M	Hold	218,725	–	–	﹤0.01%	1894
2021 Q3	$22M	Buy	218,725 +5,228	+2%	+$613K	﹤0.01%	1428
2021 Q2	$30.2M	Buy	213,497 +19,759	+10%	+$2.23M	0.01%	1274
2021 Q1	$19.3M	Sell	193,738 -7,036	-4%	-$821K	﹤0.01%	1564
2020 Q4	$24.8M	Sell	200,774 -9,279	-4%	-$1.22M	0.01%	1432
2020 Q3	$20.5M	Sell	210,053 -27,859	-12%	-$3.48M	0.01%	1407
2020 Q2	$37.1M	Sell	237,912 -11,564	-5%	-$1.76M	0.01%	1044
2020 Q1	$36M	Sell	249,476 -5,839	-2%	-$1.13M	0.01%	866
2019 Q4	$52.2M	Buy	255,315 +136,398	+115%	+$24.9M	0.01%	883
2019 Q3	$9.55M	Buy	+118,917	New	+$10.1M	﹤0.01%	1792

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Norges Bank's RETA Position: Q3 2023 in Review

Norges Bank sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 145,582 shares — an estimated $14.8M sold.

Norges Bank first reported a position in RETA in Q3 2019 and held it in 16 quarters. The position peaked at $52.2M in Q4 2019. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Norges Bank reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Norges Bank sold 145,582 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $14.8M.
Norges Bank first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2019 and held it in 16 quarters.
Norges Bank's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $52.2M in Q4 2019.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Norges Bank's 13F filing for Q3 2023, filed 13 Nov 2023.